Economic impact of different diagnostic strategies in respiratory infection - Vienna 2024

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

The value of in vitro diagnostic tests to reduce antimicrobial resistance and to improve patient outcomes

Chair(s): Chiara Premuda, Onno Akkerman, Herman Goossens

Session type: Symposium

Economic impact of different diagnostic strategies in respiratory infection

Maarten Postma

EVENTS HOME

Previous presentation

Next presentation

Session content

Enhancing antibiotic prescription quality in paediatric emergency rooms: results from the ADEQUATE trial

Julia Bielicki

Replay

Slides

Point-of-care testing to safely reduce antibiotic use in primary care: results from the PRUDENCE trial

Emma Harper

Replay

Slides

Stakeholder perspectives on implementing point-of-care tests in community care

Melanie Hoste

Replay

Slides

Economic impact of different diagnostic strategies in respiratory infection

Maarten Postma

Replay

Slides

Discussion and Q&A

Replay

The ERS Congress 2024, Vienna